• OPEN AN ACCOUNT
Indian Indices
Nifty
25,003.05 252.15
(1.02%)
Sensex
82,564.33 375.34
( 0.46%)
Bank Nifty
56,578.40 817.55
( 1.47%)
Nifty IT
37,294.85 186.90
( 0.50%)
Global Indices
Nasdaq
42,779.54 438.80
(1.04%)
Dow Jones
6,020.48 60.18
(1.01%)
Hang Seng
37,687.53 133.04
(0.35%)
Nikkei 225
8,837.91 26.87
(0.30%)
Forex
USD-INR
85.77 -0.09
(-0.10%)
EUR-INR
97.89 0.03
(0.03%)
GBP-INR
116.15 -0.09
(-0.08%)
JPY-INR
0.59 0.00
(-0.69%)

EQUITY - MARKET SCREENER

AIA Engineering Ltd
Industry :  Castings & Forgings
BSE Code
ISIN Demat
Book Value()
532683
INE212H01026
711.0249964
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AIAENG
32.36
33055.05
EPS(TTM)
Face Value()
Div & Yield %
108.3
2
0.46
 

Aurobindo Pharma arm incorporates WOS in Netherlands
May 29,2025
The purpose of the incorporation of this wholly owned subsidiary is to expand the biopharma products business in Europe.

The company has subscribed to an initial share capital of Euro 10,000, divided into 10,000 shares with a nominal value of Euro 1.00 each.

Aurobindo Pharma is an integrated global pharmaceutical company headquartered in Hyderabad, India. The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

The company’s consolidated net profit fell 0.6% to Rs 903.47 crore despite a 11.9% jump in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24.

The scrip declined 3.61% to end at Rs 1,147.95 on the BSE.